Antigua and Barbuda vs Mongolia: HIV-positive TB patients on ART (antiretroviral therapy)
Antigua and Barbuda
100.0%
in 2022
Mongolia
100.0%
in 2024
Antigua and Barbuda rank
1st
Mongolia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Antigua and Barbuda
- Mongolia
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Mongolia, a difference of 0.0%.
The two have swapped places 1 time across 7 shared years of data; in 2005 it was Mongolia ahead.
Antigua and Barbuda ranks 1st and Mongolia ranks 1st of 144 countries.
Antigua and Barbuda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 100.0% | 74.0% | 26.0% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Antigua and Barbuda or Mongolia?
- Antigua and Barbuda, at 100.0% against 100.0% in Mongolia as of 2022.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Antigua and Barbuda and Mongolia?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Mongolia?
- 7 years are reported by both, from 2005 to 2014.
- How do Antigua and Barbuda and Mongolia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Antigua and Barbuda ranks 1st and Mongolia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.